| Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Z Ye, H Zhan, P Mali, S Dowey, DM Williams, YY Jang, CV Dang, ... Blood, The Journal of the American Society of Hematology 114 (27), 5473-5480, 2009 | 472 | 2009 |
| Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera AR Moliterno, WD Hankins, JL Spivak New England Journal of Medicine 338 (9), 572-580, 1998 | 387 | 1998 |
| Platelet counts differ by sex, ethnicity, and age in the United States JB Segal, AR Moliterno Annals of epidemiology 16 (2), 123-130, 2006 | 285 | 2006 |
| Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies H Makishima, AM Jankowska, RV Tiu, H Szpurka, Y Sugimoto, Z Hu, ... Leukemia 24 (10), 1799-1804, 2010 | 221 | 2010 |
| Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ... Leukemia 27 (6), 1301-1309, 2013 | 165 | 2013 |
| Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression AR Moliterno, DM Williams, O Rogers, JL Spivak Blood 108 (12), 3913-3915, 2006 | 148 | 2006 |
| Phenotypic variations and new mutations in JAK2 V617F–negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis DM Williams, AH Kim, O Rogers, JL Spivak, AR Moliterno Experimental hematology 35 (11), 1641-1646, 2007 | 144 | 2007 |
| Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis AR Moliterno, DM Williams, LI Gutierrez-Alamillo, R Salvatori, ... Proceedings of the National Academy of Sciences 101 (31), 11444-11447, 2004 | 143 | 2004 |
| Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis A Jerez, Y Sugimoto, H Makishima, A Verma, AM Jankowska, ... Blood, The Journal of the American Society of Hematology 119 (25), 6109-6117, 2012 | 142 | 2012 |
| Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera AR Moliterno, JL Spivak Blood, The Journal of the American Society of Hematology 94 (8), 2555-2561, 1999 | 133 | 1999 |
| Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia … BL Stein, DM Williams, C O’Keefe, O Rogers, RG Ingersoll, JL Spivak, ... Haematologica 96 (10), 1462, 2011 | 128 | 2011 |
| Modified Ham test for atypical hemolytic uremic syndrome E Gavriilaki, X Yuan, Z Ye, AJ Ambinder, SP Shanbhag, MB Streiff, ... Blood, The Journal of the American Society of Hematology 125 (23), 3637-3646, 2015 | 108 | 2015 |
| Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens AR Moliterno, DM Williams, O Rogers, MA Isaacs, JL Spivak Experimental hematology 36 (11), 1480-1486. e2, 2008 | 106 | 2008 |
| Anemia of cancer AR Moliterno, JL Spivak Hematology/Oncology Clinics 10 (2), 345-362, 1996 | 105 | 1996 |
| Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders BL Stein, DM Williams, NY Wang, O Rogers, MA Isaacs, N Pemmaraju, ... Haematologica 95 (7), 1090, 2010 | 91 | 2010 |
| Polycythemia vera: an appraisal of the biology and management 10 years after the discovery of JAK2 V617F BL Stein, ST Oh, D Berenzon, GS Hobbs, M Kremyanskaya, RK Rampal, ... Journal of Clinical Oncology 33 (33), 3953, 2015 | 86 | 2015 |
| Age-related differences in disease characteristics and clinical outcomes in polycythemia vera BL Stein, S Saraf, U Sobol, A Halpern, J Shammo, D Rondelli, L Michaelis, ... Leukemia & lymphoma 54 (9), 1989-1995, 2013 | 86 | 2013 |
| Eculizumab cessation in atypical hemolytic uremic syndrome SA Merrill, ZD Brittingham, X Yuan, AR Moliterno, CJ Sperati, RA Brodsky Blood, The Journal of the American Society of Hematology 130 (3), 368-372, 2017 | 79 | 2017 |
| Two clinical phenotypes in polycythemia vera JL Spivak, M Considine, DM Williams, CC Talbot Jr, O Rogers, ... New England Journal of Medicine 371 (9), 808-817, 2014 | 76 | 2014 |
| Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies I Gomez-Segui, H Makishima, A Jerez, K Yoshida, B Przychodzen, ... Leukemia 27 (9), 1943-1946, 2013 | 69 | 2013 |
